In patients with type 2 diabetes, the class of drugs called glucagon-like peptide 1 (GLP-1) receptor agonists are highly effective for blood glucose control. They also help to reduce weight, and some may provide cardiovascular benefits. However, they’re currently only available in injectable form, “which is known to be a barrier for some patients and providers,” said Vanita R. Aroda, MD, associate director of diabetes clinical research at Brigham and Women’s Hospital in Boston.
Abbasi J. Oral GLP-1 Analog for Type 2 Diabetes on the Horizon. JAMA. 2018;320(6):539. doi:10.1001/jama.2018.11254
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: